日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Spatial-hindrance-based pro-Adalimumab prevents anti-idiotypic antibody interference in pharmacokinetic and therapeutic efficacy.

基于空间阻碍的pro-Adalimumab可防止抗独特型抗体干扰药代动力学和治疗效果

Huang Bo-Cheng, Chen Yu-Tung, Lu Yun-Chi, Ho Kai-Wen, Hong Shih-Ting, Liao Tzu-Yi, Wu I-Hsuan, Liu En-Shuo, Liao Jun-Min, Chen Fang-Ming, Li Chia-Ching, Chuang Chih-Hung, Chen Chiao-Yun, Cheng Tian-Lu

Fibrinogen-Like Protein 1 Serves as an Anti-Inflammatory Agent for Collagen-Induced Arthritis Therapy in Mice.

纤维蛋白原样蛋白 1 可作为抗炎剂用于治疗小鼠胶原蛋白诱导的关节炎

Lin Wen-Wei, Ho Kai-Wen, Su Hsiang-Han, Fang Tien-Fang, Tzou Shey-Cherng, Chen I-Ju, Lu Yun-Chi, Chang Mu-Shen, Tsai Yun-Chen, Liu En-Shuo, Su Yu-Cheng, Wang Yen-Tseng, Cheng Tian-Lu, Huang Hsin-Kai

Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy.

选择性激活促抗IL-1β抗体可增强自身炎症性疾病治疗的特异性

Lin Wen-Wei, Lu Yun-Chi, Huang Bo-Cheng, Chuang Chih-Hung, Cheng Yi-An, Chen I-Ju, Liu Hui-Ju, Ho Kai-Wen, Liao Tzu-Yi, Liu En-Shuo, Wu Ting-Yi, Chang Long-Sen, Hong Shih-Ting, Cheng Tian-Lu

Patient and provider factors associated with receipt and delivery of brief interventions for unhealthy alcohol use in primary care

与初级保健中不健康饮酒行为的简短干预措施的接受和实施相关的患者和医护人员因素

Lu, Yun; Chi, Felicia W; Parthasarathy, Sujaya; Palzes, Vanessa A; Kline-Simon, Andrea H; Metz, Verena E; Weisner, Constance; Satre, Derek D; Campbell, Cynthia I; Elson, Joseph; Ross, Thekla B; Awsare, Sameer V; Sterling, Stacy A

Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer

人源化双特异性抗体(mPEG × HER2)可快速赋予聚乙二醇化纳米颗粒肿瘤特异性,用于乳腺癌的多模态成像

Cheng, Yi-An; Wu, Tung-Ho; Wang, Yun-Ming; Cheng, Tian-Lu; Chen, I-Ju; Lu, Yun-Chi; Chuang, Kuo-Hsiang; Wang, Chih-Kuang; Chen, Chiao-Yun; Lin, Rui-An; Chen, Huei-Jen; Liao, Tzu-Yi; Liu, En-Shuo; Chen, Fang-Ming

Ab locks for improving the selectivity and safety of antibody drugs

抗体阻断剂用于提高抗体药物的选择性和安全性

Lin, Wen-Wei; Lu, Yun-Chi; Chuang, Chih-Hung; Cheng, Tian-Lu

Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy

特异性激活前体英夫利昔单抗可增强类风湿性关节炎治疗的选择性和安全性

Lu, Yun-Chi; Chuang, Chih-Hung; Chuang, Kuo-Hsiang; Chen, I-Ju; Huang, Bo-Cheng; Lee, Wen-Han; Wang, Hsin-Ell; Li, Jia-Je; Cheng, Yi-An; Cheng, Kai-Wen; Wang, Jaw-Yuan; Hsieh, Yuan-Chin; Lin, Wen-Wei; Cheng, Tian-Lu

SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study

载有SN38的<100 nm靶向脂质体可改善药物溶解度差、最大限度减少突释和毒性:体外和体内研究

Fang, Yi-Ping; Chuang, Chih-Hung; Wu, Yi-Jhun; Lin, Hsin-Che; Lu, Yun-Chi

Selective antibody activation through protease-activated pro-antibodies that mask binding sites with inhibitory domains

通过蛋白酶激活的前抗体选择性激活抗体,这些前抗体通过抑制性结构域掩盖结合位点。

Chen, I-Ju; Chuang, Chih-Hung; Hsieh, Yuan-Chin; Lu, Yun-Chi; Lin, Wen-Wei; Huang, Chien-Chiao; Cheng, Ta-Chun; Cheng, Yi-An; Cheng, Kai-Wen; Wang, Yeng-Tseng; Chen, Fang-Ming; Cheng, Tian-Lu; Tzou, Shey-Cherng

Addiction treatment ultimatums and U.S. health reform: A case study

成瘾治疗最后通牒与美国医疗改革:案例研究

Weisner, Constance; Hinman, Agatha; Lu, Yun; Chi, Felicia W; Mertens, Jennifer